Body fat redistribution (BFR) syndrome: Difference between revisions

Jump to navigation Jump to search
Gerald Chi (talk | contribs)
mNo edit summary
Gerald Chi (talk | contribs)
mNo edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}


{{SK}} Body fat redistribution; fat derangement; fat redistribution
{{SK}} BFR; Body fat redistribution; fat derangement; fat redistribution


==Overview==
==Overview==

Revision as of 15:29, 11 February 2015

WikiDoc Resources for Body fat redistribution (BFR) syndrome

Articles

Most recent articles on Body fat redistribution (BFR) syndrome

Most cited articles on Body fat redistribution (BFR) syndrome

Review articles on Body fat redistribution (BFR) syndrome

Articles on Body fat redistribution (BFR) syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Body fat redistribution (BFR) syndrome

Images of Body fat redistribution (BFR) syndrome

Photos of Body fat redistribution (BFR) syndrome

Podcasts & MP3s on Body fat redistribution (BFR) syndrome

Videos on Body fat redistribution (BFR) syndrome

Evidence Based Medicine

Cochrane Collaboration on Body fat redistribution (BFR) syndrome

Bandolier on Body fat redistribution (BFR) syndrome

TRIP on Body fat redistribution (BFR) syndrome

Clinical Trials

Ongoing Trials on Body fat redistribution (BFR) syndrome at Clinical Trials.gov

Trial results on Body fat redistribution (BFR) syndrome

Clinical Trials on Body fat redistribution (BFR) syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Body fat redistribution (BFR) syndrome

NICE Guidance on Body fat redistribution (BFR) syndrome

NHS PRODIGY Guidance

FDA on Body fat redistribution (BFR) syndrome

CDC on Body fat redistribution (BFR) syndrome

Books

Books on Body fat redistribution (BFR) syndrome

News

Body fat redistribution (BFR) syndrome in the news

Be alerted to news on Body fat redistribution (BFR) syndrome

News trends on Body fat redistribution (BFR) syndrome

Commentary

Blogs on Body fat redistribution (BFR) syndrome

Definitions

Definitions of Body fat redistribution (BFR) syndrome

Patient Resources / Community

Patient resources on Body fat redistribution (BFR) syndrome

Discussion groups on Body fat redistribution (BFR) syndrome

Patient Handouts on Body fat redistribution (BFR) syndrome

Directions to Hospitals Treating Body fat redistribution (BFR) syndrome

Risk calculators and risk factors for Body fat redistribution (BFR) syndrome

Healthcare Provider Resources

Symptoms of Body fat redistribution (BFR) syndrome

Causes & Risk Factors for Body fat redistribution (BFR) syndrome

Diagnostic studies for Body fat redistribution (BFR) syndrome

Treatment of Body fat redistribution (BFR) syndrome

Continuing Medical Education (CME)

CME Programs on Body fat redistribution (BFR) syndrome

International

Body fat redistribution (BFR) syndrome en Espanol

Body fat redistribution (BFR) syndrome en Francais

Business

Body fat redistribution (BFR) syndrome in the Marketplace

Patents on Body fat redistribution (BFR) syndrome

Experimental / Informatics

List of terms related to Body fat redistribution (BFR) syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: BFR; Body fat redistribution; fat derangement; fat redistribution

Overview

Body fat redistribution (BFR) syndrome, sometimes called fat derangement, is a medical condition characterized by fat loss (or occasionally fat gain), often in the cheeks or face. BFR most often occurs in HIV/AIDS patients undergoing antiretroviral therapy.

No firm definition of body fat redistribution syndrome exists as yet. At least four syndromes have been described that are characterized by the accumulation of fat, and one by the loss of fat; combinations of these may occur in an individual. Gender, age, and pre-therapy body weight appear to influence the severity of BFR in patients. BFR is distinct from lipodystrophy, which simply refers to fat loss.

Causes

Common Causes

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect

Stavudine

Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease No underlying causes
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic No underlying causes
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy No underlying causes
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous No underlying causes

Causes in Alphabetical Order

The unnamed parameter 2= is no longer supported. Please see the documentation for {{columns-list}}.
3

Symptoms

The most common manifestations of body fat redistribution are accumulations of fat in the central body in the form of a fat pad on the back of the neck and an accumulation of visceral fat in the abdomen or belly. This fat accumulation is accompanied by a loss of subcutaneous fat in the face, arms, legs, and buttocks.

Patient #1: HIV patient developed fat redistribrution syndrome while on HAART

Adverse effects

Cosmetic concerns may cause patients to refuse or stop treatment. If severe enough, the fat accumulation may result in sleep apnea or other sleep disorders, migraines, decreased range of motion, discomfort due to pressure on internal organs, and general loss of condition. Fat loss may result in pain in the buttocks when seated. Other potential complications resulting from BFR include high cholesterol, high levels of triglycerides, insulin resistance, hyperglycemia, diabetes, gout, and cardiovascular disease. BFR is also associated with certain metabolic abnormalities such as elevations of plasma sugar and fats, but the precise relationship is unknown.

Treatment

Treatment of symptoms may include cosmetic surgery such as collagen implants; treatment of the underlying syndrome may include changing from protease inhibitors to an NNRTI.

Related Chapters

References

Template:Disease-stub

Template:WS